Reuters logo
BRIEF-Progenics Pharmaceuticals reports Q1 loss per share $0.23
May 4, 2017 / 12:34 PM / 5 months ago

BRIEF-Progenics Pharmaceuticals reports Q1 loss per share $0.23

May 4 (Reuters) - Progenics Pharmaceuticals Inc:

* Progenics pharmaceuticals announces first quarter 2017 financial results and business update

* Q1 loss per share $0.23

* Q1 earnings per share view $-0.19 -- Thomson Reuters I/B/E/S

* Progenics Pharmaceuticals Inc - company on track to submit NDA in mid-2017 for Azedra

* Progenics pharmaceuticals inc - Q1 revenue totaled $2.3 million, down from $2.5 million in q1 of 2016

* Q1 revenue view $4.5 million -- Thomson Reuters I/B/E/S

* Progenics Pharmaceuticals Inc - ended quarter with cash and cash equivalents of $126.3 million, a sequential decrease of $12.6 million Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below